Skip to main content
L&K BIOMED CO., LTD. logo

L&K BIOMED CO., LTD. — Investor Relations & Filings

Ticker · 156100 ISIN · KR7156100000 KO Manufacturing
Open in API
Filings indexed 359 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 156100

About L&K BIOMED CO., LTD.

https://www.lnkbiomed.com

L&K BIOMED CO., LTD. is a global medical device company specializing in the development, manufacturing, and marketing of orthopedic spinal implants. The company's product portfolio is designed to treat a variety of spinal diseases and includes solutions such as the Anterior Cervical Plate System, Posterior Cervical Screw System, and Cervical Cage Systems. With a strong emphasis on research and development, L&K BIOMED focuses on creating innovative and high-quality technologies to advance spinal health and contribute to the broader medical industry.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the 19th fiscal year, first quarter (2026-01-01 to 2026-03-31). It contains substantive financial statements, operational metrics, and business analysis for the quarter. This aligns directly with an Interim/Quarterly Report (IR), not merely an announcement or supplementary notice. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 89% confidence The document is a “주식등의 대량보유상황보고서(일반)” – a statutory report filed under Korean capital markets law disclosing the number of shares and percentage held by a major shareholder and its related parties, along with changes and acquisition details. It is not an AGM, annual or interim report, earnings release, call transcript, or proxy statement. It is specifically a major shareholding notification, matching our MRQ category.
2026-04-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a ‘주식등의 대량보유상황보고서(일반)’ filed under the Capital Markets Act, detailing the quantity and changes of shares held by a major shareholder and related parties, with dates of occurrence and percentages. It is not an earnings release, management discussion, or proxy statement but a regulatory notification of significant shareholding changes. This corresponds to the 'Major Shareholding Notification' category (MRQ).
2026-04-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of an outside director for the company L&K Biomed. This falls under the category of board and management changes.
2026-03-20 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Annual General Meeting (AGM), detailing the voting outcomes for various agenda items such as financial statement approval, director appointments, and remuneration limits. It explicitly lists '정기주주총회결과' (Regular General Meeting Results) as the title and provides a breakdown of voting results, which aligns perfectly with the definition for Declaration of Voting Results & Voting Rights Announcements.
2026-03-20 Korean
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for L&K Biomed, which is the Korean equivalent of a 10-K annual report. It contains comprehensive financial data, management discussion, corporate governance details, and audit information for the fiscal year 2025. It is not an announcement of a report, but the report itself. FY 2025
2026-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.